Reaction Details |
| Report a problem with these data |
Target | Kappa-type opioid receptor |
---|
Ligand | BDBM86931 |
---|
Substrate/Competitor | n/a |
---|
Ki | 4.50±n/a nM |
---|
Comments | PDSP_8465 |
---|
Citation | Ghirmai, S; Azar, MR; Polgar, WE; Berzetei-Gurske, I; Cashman, JR Synthesis and biological evaluation of alpha- and beta-6-amido derivatives of 17-cyclopropylmethyl-3, 14beta-dihydroxy-4, 5alpha-epoxymorphinan: potential alcohol-cessation agents. J Med Chem51:1913-24 (2008) [PubMed] Article |
---|
More Info.: | Get all data from this article |
---|
|
Kappa-type opioid receptor |
---|
Name: | Kappa-type opioid receptor |
Synonyms: | K-OR-1 | KOR-1 | Kappa-opioid receptor (KOR) | Kappa-type opioid receptor (KOPR) | Kappa-type opioid receptor (KOR) | Kappa-type opioid receptor (Kappa) | OPIATE Kappa | OPRK | OPRK1 | OPRK_HUMAN | kappa opioid receptor (KOR) |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 42648.76 |
Organism: | Homo sapiens (Human) |
Description: | P41145 |
Residue: | 380 |
Sequence: | MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPV
IITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYL
MNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINI
CIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVL
IIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALG
STSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRV
RNTVQDPAYLRDIDGMNKPV
|
|
|
BDBM86931 |
---|
n/a |
---|
Name | BDBM86931 |
Synonyms: | 17-cyclopropylmethyl-3,14-beta-dihydroxy-4,5-alpha-epoxy-6-alpha-[(D-glucopyranosyl)acetamido]morphinan | 17-cyclopropylmethyl-3,14-beta-dihydroxy-4,5-alpha-epoxy-6-beta-(D-glucopyranosyl)acetamido]morphinan | CAS_24822461 | CAS_24824634 | NSC_24822461 | NSC_24824634 |
Type | Small organic molecule |
Emp. Form. | C28H38N2O9 |
Mol. Mass. | 546.6093 |
SMILES | OCC1OC(CC(=O)NC2CCC3(O)C4Cc5ccc(O)c6OC2C3(CCN4CC2CC2)c56)C(O)C(O)C1O |TLB:11:12:27.26.25:15.16.32,THB:13:12:27.26.25:15.16.32| |
Structure |
|